Create issue ticket

47 Possible Causes for 3,5 diiodothyropropionic, acid

Show results in: Română

  • Bezafibrate

    Hypolipidemic Agents Peroxisome Proliferator-Activated Receptors Recombinant Proteins hexacosanoic acid Acetyltransferases fatty acid elongases Bezafibrate[ncbi.nlm.nih.gov] (S)-Warfarin The risk or severity of bleeding can be increased when Bezafibrate is combined with (S)-Warfarin. 3,5-diiodothyropropionic acid The metabolism of 3,5-diiodothyropropionic[drugbank.ca] Except for the reduction in plasma triglycerides, ω-3 fatty acids produced no effect on the lipid profile and insulin sensitivity.[ncbi.nlm.nih.gov]

  • Mitoxantrone

    Abstract Hyaluronic acid (HA) has inherent ability to target the CD44 receptors and internalize into tumour cells via receptor-mediated endocytosis.[ncbi.nlm.nih.gov] […] when combined with Mitoxantrone. 5-androstenedione The metabolism of 5-androstenedione can be decreased when combined with Mitoxantrone. 6-O-benzylguanine The metabolism[drugbank.ca] Citations 1 to 3 of 3 total Rated 5 out of 5 by ET from mielov mielov , J. et al.[scbt.com]

  • Arsenic Trioxide

    BACKGROUND: Recently, the all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) protocol has become a promising first-line therapeutic approach in patients with newly[ncbi.nlm.nih.gov] […] when combined with Arsenic trioxide. 5-androstenedione The metabolism of 5-androstenedione can be decreased when combined with Arsenic trioxide. 6-O-benzylguanine The metabolism[drugbank.ca] We describe 3 patients in whom this arrhythmia developed while they were treated with arsenic trioxide.[ncbi.nlm.nih.gov]

  • Orlistat

    […] cancers, is responsible for palmitic acid biosynthesis.[ncbi.nlm.nih.gov] […] when combined with Orlistat. 5-androstenedione The metabolism of 5-androstenedione can be increased when combined with Orlistat. 6-O-benzylguanine The metabolism of 6-O-benzylguanine[drugbank.ca] The results revealed a concentration and time-dependent decrease in the proliferation of HSC-3 cells by orlistat.[ncbi.nlm.nih.gov]

  • Ivermectin

    Here, we studied the structure of a member of the Cys-loop ligand gated ion channel protein superfamily of receptors, human type A γ 2 α 1 β 2 α 1 β 2 gamma amino butyric acid[ncbi.nlm.nih.gov] (S)-Warfarin Ivermectin may decrease the anticoagulant activities of (S)-Warfarin. 3,5-diiodothyropropionic acid The metabolism of 3,5-diiodothyropropionic acid can be decreased[drugbank.ca] Br J Dermatol. 2013;169(4):931-3 [2] During a 3-year study, both the proportion of children with haematuria and its mean level fell while the prevalence of scabies dropped[pbs.gov.au]

  • Amphotericin B

    From the array of fatty acids, the oleic acid (OA) was selected for conjugation due to its great impact on increasing the Caco-2 permeability of AmB.[ncbi.nlm.nih.gov] (S)-Warfarin The risk or severity of bleeding can be increased when Amphotericin B is combined with (S)-Warfarin. 3,5-diiodothyropropionic acid The metabolism of 3,5-diiodothyropropionic[drugbank.ca] Solutions in tissue culture media are stable for 3 days at 37 C. Documentation SDS Certificates of Analysis References Reference overview Tollemar, J., et al. 1995.[emdmillipore.com]

  • Pilocarpine

    Given that this modification determines final therapeutic efficacy of drug carriers, here, we investigate systematically the role of grafting amount of antioxidant gallic acid[ncbi.nlm.nih.gov] […] when combined with Pilocarpine. 5-androstenedione The metabolism of 5-androstenedione can be decreased when combined with Pilocarpine. 6-O-benzylguanine The metabolism of[drugbank.ca] RESULTS: ACV increased significantly after LPI (from a mean standard error of 94.6 3.6 mm(3) to 108.8 3.4 mm(3), P CONCLUSIONS: Scheimpflug photography demonstrates significant[ncbi.nlm.nih.gov]

  • Zileuton

    KEY RESULTS: Zileuton suppressed PG biosynthesis by interference with arachidonic acid (AA) release in macrophages.[ncbi.nlm.nih.gov] […] when combined with Zileuton. 5-androstenedione The metabolism of 5-androstenedione can be decreased when combined with Zileuton. 6-Deoxyerythronolide B The metabolism of Zileuton[drugbank.ca] Elevations in alanine aminotransferase levels at least 3 times the upper limit of normal that reversed after drug withdrawal were seen in 5 zileuton CR-treated patients (2.5%[ncbi.nlm.nih.gov]

  • Metyrapone

    Abstract Alprazolam (ALP), a benzodiazepine that activates gamma-aminobutyric acid-ergic receptors, inhibits the activity of hypothalamo-pituitary-adrenal (HPA) axis, probably[ncbi.nlm.nih.gov] (S)-Warfarin The metabolism of (S)-Warfarin can be increased when combined with Metyrapone. 3,5-diiodothyropropionic acid The metabolism of 3,5-diiodothyropropionic acid can[drugbank.ca] […] pregnane-3 alpha,11 beta,17,20 alpha,21-pentol, plus pregnane-3 alpha,11 beta,17,20 beta-21-pentol (cortol), and 3 alpha,17,20 alpha,21-tetrahydroxypregnan-11-one (cortolone[ncbi.nlm.nih.gov]

  • Isosorbide

    It was found that the kind of carboxylic acid used in the foaming system influenced compressive strength and compressive modulus of porous scaffolds.[ncbi.nlm.nih.gov] (S)-Warfarin The metabolism of (S)-Warfarin can be decreased when combined with Isosorbide dinitrate. 3,5-diiodothyropropionic acid The metabolism of 3,5-diiodothyropropionic[drugbank.ca] OBJECTIVES: The purpose of this study was to evaluate the influence of the guanine nucleotide-binding proteins (G-proteins), beta-3 subunit (GNB3) genotype on the effectiveness[ncbi.nlm.nih.gov]